Case Studies

Adelphi Values is a global healthcare value consultancy. Many of our projects help facilitate patient and healthcare provider access to appropriate treatment.

The case studies below represent a small sample of the projects performed by our global team, including projects related to HTA submissions, patient-reported outcomes, the regulatory process, and formulary inclusion. For confidentiality reasons, client and product names have been removed.

Communicating the value of vaccines to global payers

Developing a payer value deck to support regional payer discussions and promote reimbursement in ex-US countries
Read More

Cost comparison model of a novel treatment for venous thromboembolism

Development of a flexible and interactive model for Japan
Read More

Defining and demonstrating value for a novel medical device in a crowded disease area

Developing a compelling evidence-based value proposition to support reimbursement in key European markets
Read More

Defining the wider burden of illness to support the launch of a breakthrough oncology therapy in Europe

Systematic evidence review, burden quantification and effective results dissemination
Read More

Delivering an EU market access interactive training workshop

Imparting in-house expertise and knowledge to raise awareness of the challenges and opportunities of the EU market access environment
Read More

Demonstrating the cost-saving potential of biosimilars across multiple indications

Developing budget impact models (BIMs) to visually demonstrate the economic value and cost‑saving potential of biosimilars
Read More

Demonstrating the economic value of a new device

Proof of concept cost utility modelling, incorporating a pricing scenario
Read More

Demonstrating value for a portfolio of biosimilar products across a range of therapy areas

Communicating effective value demonstration for our client’s portfolio of biosimilars to facilitate discussions with payers
Read More

Developing value communication tools for in-field market access teams

A suite of presentations to identify the burden of disease, demonstrate the product value, and anticipate objections from payers
Read More

Early cost-utility model to support product positioning and future HTA submissions

Supporting internal decision-making by providing an early indication of cost-effectiveness
Read More

Elicitation of health state utilities across six global markets

Development of health states and execution of time trade off (TTO) interviews to provide utility inputs to a cost effectiveness model
Read More

Enabling timely updates to complex data sets and tailored materials

Utilising e-v@luate, our bespoke digital evidence platform, to update tailored presentations and reports centrally and disseminate rapidly
Read More

European deep dive reimbursement review to inform the market access strategy for a product in an orphan indication

Defining evidence requirements for reimbursement in five EU countries
Read More

European value strategy review for a surgical device

Combining gap and landscape analysis with payer research to optimise market access
Read More

Exploring the cost of illness of a rare disease in the UK

Presentation of primary and secondary care database analyses
Read More

Framework for real-life data generation and communication

Development of a toolkit via an interactive platform to provide easy access to current evidence and future research guidance for affiliates
Read More

Identifying and ensuring strategic alignment on the value drivers and evidence base across 14 European markets

Gap analysis to inform a strategic plan for continued market access
Read More

Identifying unmet needs in a crowded therapy area to support regulatory approval

Conducting an extensive literature review of the burden of illness and unmet medical needs in an autoimmune disease for a European regulatory submission
Read More

Informing future evidence generation through literature review and landscape analysis

Insight and direction for strategic development plans to optimise market access and returns on investment
Read More

Making complex value evidence compelling, targeted and accessible

Tailoring presentations and reports based on local need utilising e-v@luate, our bespoke digital evidence platform
Read More